This is a preview of subscription content, log in via an institution to check access.
Notes
Costs (2008 values) were from a healthcare system perspective, with future costs and outcomes discounted at 3% per annum.
Reference
Ciaranello AL, et al. Cost-effectiveness of World Health Organization 2010 Guidelines for Prevention of Mother-to-Child HIV Transmission in Zimbabwe. Clinical Infectious Diseases : 30 Nov 2012. Available from: URL: http://dx.doi.org/10.1093/cid/cis858
Rights and permissions
About this article
Cite this article
Which strategy is best for PMTCT of HIV in Zimbabwe?. PharmacoEconomics & Outcomes News 669, 8 (2013). https://doi.org/10.1007/s40274-013-0059-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0059-5